Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose methoxyflurane versus standard care for trauma pain in Dutch emergency medical services
NL-OMON50181Phase 3Active, not recruiting
- Sponsor
- Mundipharma
- Start
- Dec 2019
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute pain due to extremity trauma comparing Low-dose methoxyflurane with Standard of care (2 arms). Started Dec 2019; status: active, not recruiting.
02
Drugs
methoxyflurane
03
Conditions
acute pain due to extremity trauma
Beyond the preview
Go deeper on NL-OMON50181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50181.